Stem cell therapy in perspective

Circulation

Volumn 107, Issue 7, 2003, Pages 929-934

  Strauer, Bodo E ^a   Kornowski, Ran ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CELL DIFFERENTIATION; EMBRYO CELL; HEART FAILURE; HEART INJURY; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL TRANSPLANTATION; TREATMENT PLANNING; WOUND HEALING;

ADULT; CELL DIFFERENTIATION; CORONARY CIRCULATION; EMBRYO; ENVIRONMENT; HEART; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; STEM CELLS; WOUND HEALING;

EID: 0037465532     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000057525.13182.24     Document Type: Short Survey

References (28)

1. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 2001;108:407-414.
2. Zhang YM, Hartzell C, Narlow M, et al. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation. 2002;106: 1294-1299.
3. Strauer BE, Brehm M, Zeus T, et al. Intrakoronare, humane autologue Stammzelltransplantation zur Myokardregeneration nach Herzinfarkt. Dtsch Med Wsch. 2001;126:932-938.
4. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.
5. Epstein SE, Fuchs S, Zhou YF, et al. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res. 2001;49:532-542.
6. Buschmann I, Schaper W. Arteriogenesis versus angiogenesis: two mechanisms of vessel growth. News Physiol Sci. 1999;14:121-125.
7. Asahara T, Masuda A, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-228.
8. Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001;103:634-637.
9. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 1999; 100(suppl 11):11247-11256.
10. Laflamme MA, Myerson D, Saffitz JE, et al. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res. 2002;90:634-640.
11. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344:1750-1757.
12. Taylor DA, Hruban R, Rodriguez R, et al. Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree? Circulation. 2002;106:2-4.
13. Pittenger MF, Marshak DR. Mesenchymal stem cells of human adult bone marrow. In Marshak R. Gardner RL. Gottlieb D, eds. Stem Cell Biology. New York, NY: Cold Spring Harbor Laboratory Press; 2001: 949-973.
14. Toma C, Pittenger MF, Cahill KS. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93-98.
15. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913-1918.
16. Kornowski R, Fuchs S, Leon MB, et al. Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation. 2000;101:454-458.
17. Fuchs S, Weisz G, Kornowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility and safety study. Circulation. 2002; 106(suppl II):II655-II656.
18. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol. 2001;37:1726-1732.
19. Losordo DW, Vale PR, Hendel RC, et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation. 2002;105:2012-2018.
20. Menasche B, Hagege AA, Scorsin M. Myoblast transplantation for heart failure. Lancet. 2001;357:279-280.
21. Hamano K, Nishida M, Hirata K. Local implantation of autologeous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J. 2001;65:845-847.
22. Sinclair A. Genetics 101: cytogenetics and FISH. CMAJ. 2002;167:373-374.
23. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-436.
24. Orlic D, Kajstura T, Chimenti S. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001;98:10344-10349.
25. Friedenstein AF. Precursor cells of mechanocytes. Int Rev Cytol. 1976;47:327-355.
26. Hare JM. Cardiac-resynchronization therapy for heart failure. N Engl J Med. 2002;346:1902-1905.
27. Gregoric I, Frazier OF, Couto WJ. Surgical treatment of congestive heart failure. Congest Heart Fail. 2002;8:214-219.
28. Strauer BE. Myocardial oxygen Consumption in chronic heart disease: role of wall stress, hypertrophy and coronary reserve. Am J Cardiol. 1979;44:730-740.